SynAct Pharma AB Announces Change in Nomination Committee Prior to Agm 2023
Following the change, the Nomination Committee for the 2023 Annual General Meeting consists of the following persons: Niels Ankerstjerne Sloth, appointed by Bioinvest ApS; Per Colleen, appointed by TomEnterprise Public Capital AB; Jens Bager, appointed by GL Capital AB; and Torbjørn Bjerke, Chairman of the Board. Jens Bager remains as Chairman of the Nomination Committee.